Scarica l'app Stockscreener
22.65
1.99%
-0.42
Ceribell Inc Borsa (CBLL) Ultime notizie
Is CeriBell Inc. stock a buy on dips2025 Top Decliners & Long-Term Safe Return Strategies - ulpravda.ru
Why CeriBell Inc. stock could outperform in 2025RSI Overbought/Oversold & Learn the Basics of Investing in 5 Days - ulpravda.ru
Ceribell’s Foehr sells $125k in shares after option exercise By Investing.com - Investing.com Nigeria
Ceribell CEO Chao Xingjuan sells $1.68 million in shares By Investing.com - Investing.com South Africa
Ceribell CEO Chao Xingjuan sells $1.68 million in shares - Investing.com
Pittsburgh Post-GazetteCeriBell, Inc.Common Stock (Nasdaq:CBLL) Stock Quote - FinancialContent
Will CeriBell Inc. stock benefit from infrastructure spending2026 world cup usa national team group stage star players transition play winner prediction breakdown - ulpravda.ru
Ceribell director resigns to pursue other professional ventures - MSN
Ceribell Gets FDA Breakthrough Device Status - Medical Device and Diagnostic industry
Ceribell’s AI Stroke Detection Tool Gains FDA Breakthrough Status - Zenopa
CBLL Wins FDA Breakthrough Status for AI-Based LVO Stroke Detection - Yahoo Finance
Protara, Ceribell rise on FDA breakthrough designations - MSN
FDA grants breakthrough designation for Ceribell’s stroke detection monitor By Investing.com - Investing.com Nigeria
Ceribell receives FDA breakthrough device designation for LVO SD monitor - TipRanks
Ceribell shares advance after FDA grants breakthrough device status - MSN
CeriBell (NASDAQ:CBLL) Hits New 12-Month HighHere's Why - MarketBeat
Ceribell Wins FDA Breakthrough Status for LVO Stroke Tool - TipRanks
Ceribell, Inc. Receives FDA Breakthrough Device Designation for LVO Stroke Solution - TradingView — Track All Markets
Protara, CeriBell rise on FDA breakthrough designations (TARA:NASDAQ) - Seeking Alpha
Ceribell receives FDA breakthrough device designation for LVO stroke detection - MarketScreener
Ceribell’s LVO Stroke Detection Monitor Wins FDA Breakthrough Nod - Medical Product Outsourcing
CeriBell stock climbs after FDA Breakthrough Device Designation By Investing.com - Investing.com Nigeria
FDA grants breakthrough designation for Ceribell’s stroke detection monitor - Investing.com
FDA highlights new brain monitor that may spot deadly hospital strokes sooner - Stock Titan
Ceribell director Lucian Iancovici resigns from board and committees By Investing.com - Investing.com Nigeria
Ceribell director Lucian Iancovici resigns from board and committees - Investing.com
Ceribell, Inc. Announces Board Resignation - TradingView — Track All Markets
CeriBell, Inc. Announces Resignation of Lucian Iancovici as Chair of the Nominating and Corporate Governance Committee and as Member of the Compensation Committee, Effective as of December 31, 2025 - marketscreener.com
CeriBell stock climbs after FDA Breakthrough Device Designation - Investing.com
Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewswire
CeriBell (NASDAQ:CBLL) CFO Sells $756,000.00 in Stock - MarketBeat
Ceribell’s CFO Blumberg sells $756k in shares By Investing.com - Investing.com Canada
Ceribell’s CFO Blumberg sells $756k in shares - Investing.com India
CeriBell (NASDAQ:CBLL) Trading 3.4% HigherHere's What Happened - MarketBeat
CeriBell, Inc. (CBLL) Eps Diluted (Quarterly) - Zacks Investment Research
CeriBell raises 2025 revenue guidance to $89M while targeting deeper hospital penetration and expanding pediatric market - MSN
Ceribell (CBLL) price target increased by 13.29% to 28.56 - MSN
Squarepoint Ops LLC Takes Position in CeriBell, Inc. $CBLL - MarketBeat
Can CeriBell Stock Hold Up When Markets Turn? - Trefis
CeriBell (CBLL) Price Target Increased by 13.29% to 28.56 - Nasdaq
Aug Catalysts: Will CeriBell Inc. stock rally after Fed decisions2025 Momentum Check & Safe Entry Point Identification - moha.gov.vn
Will CeriBell Inc. stock rally after Fed decisionsGlobal Markets & AI Enhanced Trade Execution Alerts - DonanımHaber
Market Fear: Why CeriBell Inc. stock could outperform in 2025Weekly Profit Report & Reliable Price Breakout Signals - Улправда
Ceribell management to meet virtually with BTIG - MSN
Is CeriBell Inc. stock attractive for income investorsMarket Risk Report & Low Risk High Reward Trade Ideas - Улправда
Ceribell price target raised to $30 from $29 at Canaccord - TipRanks
CeriBell (NASDAQ:CBLL) Director Sells $537,250.00 in Stock - MarketBeat
0.54%
0.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):